Document:

EX-10.1

 Exhibit 10.1 

FIRST AMENDMENT 
 TO THE
PULMATRIX, INC. AMENDED AND RESTATED 2013 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN 
 This FIRST AMENDMENT TO THE
PULMATRIX, INC. AMENDED AND RESTATED 2013 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN (this “Amendment”), dated as of June 5, 2018, is made and entered into by Pulmatrix, Inc., a Delaware corporation (the
“Company”), subject to approval by the Company’s stockholders. Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the
Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan (the “Incentive Plan”). 

RECITALS 
 WHEREAS,
the Company sponsors and maintains the Incentive Plan in order to attract and retain the services of key employees, consultants, and directors of the Company and its affiliates; 

WHEREAS, Section 32 of the Incentive Plan permits the Board of Directors of the Company (the “Board”) to
amend the Incentive Plan; 
 WHEREAS, upon the adoption of the Incentive Plan, subject to adjustment, the Company initially reserved
a total of 6,853,319 shares of its Common Stock to be issued pursuant to awards under the Incentive Plan; 
 WHEREAS, on
June 15, 2015, the Company effected a 1-for-2.5 reverse stock split of its issued and outstanding Common Stock such that, after giving effect to the reverse stock
split and other adjustments, there were 2,713,261 shares of Common Stock initially reserved for issuance under the Incentive Plan; 

WHEREAS, in accordance with the “evergreen” provision in the Incentive Plan, the number of shares of Common Stock reserved
for issuance under the Incentive Plan was automatically increased on January 1, 2016, January 1, 2017, and January 1, 2018 by 737,288 shares, 742,526 shares, and 903,600 shares, respectively, for a total of 5,096,675 shares reserved
for issuance under the Incentive Plan; 
 WHEREAS, the Board desires to amend the Incentive Plan to (i) increase the aggregate
number of shares of Common Stock that are reserved and may be delivered pursuant to awards under the Incentive Plan by an additional 7,403,325 shares, for an aggregate maximum total of 12,500,000 shares available under the Incentive Plan (on a
post-split basis), and (ii) modify the Incentive Plan’s evergreen provision by removing the cap on the number of shares that may be reserved for issuance, so that on January 1st of each
year, commencing on January 1, 2019, the number of shares reserved for issuance under the Incentive Plan will automatically increase by 5% of the number of outstanding shares of Common Stock on such date; and 

WHEREAS, as of the date hereof, the Board resolved that this Amendment be adopted and that the Incentive Plan be amended as set forth
herein. 
 NOW, THEREFORE, in accordance with Section 32 of the Incentive Plan, and subject to the approval of the
Company’s stockholders, the Company hereby amends the Incentive Plan, effective as of the date hereof, as follows: 

1.    Section 3 of the Incentive Plan is hereby amended by deleting said section in its entirety and
substituting in lieu thereof the following new Section 3: 
 3.     SHARES
SUBJECT TO THE PLAN. 
 (a)    The number of Shares which may be issued from time to time pursuant to
this Plan shall be 12,500,000, or the equivalent of such number of Shares after the Administrator, in its 

 
sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with Paragraph 25 of the Plan. ISOs may be
issued for up to 12,500,000 Shares issuable pursuant to this Plan. 
 (b)    Notwithstanding Subparagraph
(a) above, on the first day of each calendar year of the Company during the period beginning in calendar year 2019, the number of Shares that may be issued from time to time pursuant to the Plan, shall be increased by an amount equal to 5% of
the number of outstanding shares of Common Stock on such date. 
 (c)    If an Option ceases to be
“outstanding”, in whole or in part (other than by exercise), or if the Company shall reacquire (at not more than its original issuance price) any Shares issued pursuant to a Stock Grant or Stock-Based Award, or if any Stock Right expires
or is forfeited, cancelled, or otherwise terminated or results in any Shares not being issued, the unissued or reacquired Shares which were subject to such Stock Right shall again be available for issuance from time to time pursuant to this Plan.
Notwithstanding the foregoing, if a Stock Right is exercised, in whole or in part, by tender of Shares or if the Company or an Affiliate’s tax withholding obligation is satisfied by withholding Shares, the number of Shares deemed to have been
issued under the Plan for purposes of the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of Shares actually issued, and any Stock
Appreciation Right to be settled in shares of Common Stock shall be counted in full against the number of Shares available for issuance under the Plan, regardless of the number of exercise gain shares issued upon the settlement of the Stock
Appreciation Right. However, in the case of ISOs, the foregoing provisions shall be subject to any limitations under the Code. 

2.    Except as expressly amended by this Amendment, the Incentive Plan shall continue in full force
and effect in accordance with the provisions thereof. 
 * * * * * * * * 

  
 2 

 IN WITNESS WHEREOF, the Company has caused this Amendment to be duly executed as of the
date first written above. 
  

			
	PULMATRIX, INC.
		
	By:	 	 /s/ Robert W. Clarke

	Name:	 	 Robert W. Clarke

	Title:	 	 Chief Executive Officer

  
 3Exhibit
10.1

 

Form
of Indemnification Agreement

 

Indemnification
of Directors and Officers

 

NRS
78.502 of Chapter 78 of the Nevada Private Corporations Law authorizes a court to award, or a corporation's board of directors
to grant, indemnity to directors and officers under certain circumstances and subject to certain limitations. The terms of NRS
78.502 of Chapter 78 of the Nevada Private Corporations Law are sufficiently broad to permit indemnification under certain circumstances
for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended (the Securities
Act).

 

As
permitted by the Nevada Private Corporations, the Registrant's restated certificate of incorporation that will be in effect at
the closing of the offering contains provisions that eliminate the personal liability of its directors for monetary damages for
any breach of fiduciary duties as a director, except liability for the following:

 

		●	any
                                         breach of the director's duty of loyalty to the Registrant or its stockholders;
	 	 	 
		●	acts
                                         or omissions not in good faith or that involve intentional misconduct or a knowing violation
                                         of law;
	 	 	 
		●	Under
                                         NRS 78.300 of Nevada Private Corporation Law (regarding unlawful dividends and stock
                                         purchases); or
	 	 	 
		●	any
                                         transaction from which the director derived an improper personal benefit.

 

As
permitted by the Nevada Private Corporation Law, the Registrant's restated bylaws that will be in effect at the closing of our
initial public offering, provide that:

 

		●	the
                                         Registrant is required to indemnify its directors and executive officers to the fullest
                                         extent permitted by the Nevada Private Corporation Law, subject to very limited exceptions;
	 	 	 
		●	the
                                         Registrant may indemnify its other employees and agents as set forth in the Nevada Private
                                         Corporation Law;
	 	 	 
		●	the
                                         Registrant is required to advance expenses, as incurred, to its directors and executive
                                         officers in connection with a legal proceeding to the fullest extent permitted by the
                                         Nevada Private Corporation Law, subject to very limited exceptions; and
	 	 	 
		●	the
                                         rights conferred in the bylaws are not exclusive.

 

The
Registrant has entered, and intends to continue to enter, into separate indemnification agreements with its directors and executive
officers to provide these directors and executive officers additional contractual assurances regarding the scope of the indemnification
set forth in the Registrant's restated certificate of incorporation and restated bylaws and to provide additional procedural protections.
At present, there is no pending litigation or proceeding involving a director or executive officer of the Registrant regarding
which indemnification is sought. The indemnification provisions in the Registrant's restated certificate of incorporation, restated
bylaws and the indemnification agreements entered into or to be entered into between the Registrant and each of its directors
and executive officers may be sufficiently broad to permit indemnification of the Registrant's directors and executive officers
for liabilities arising under the Securities Act.Exhibit 10.5

 

Trademark License Agreement

 

This Trademark License Agreement
(this “Agreement”) is made effective as of June 22, 2011 between Ann Shapiro, of 20585 N. 95th St., Scottsdale,
Arizona 85255 and Arrestage International Inc., of 297 Kingsbury Grade Suite 100 MB 4470, Stateline, Nevada 89449.

 

In the Agreement, the party who is
granting the right to use the licensed property will be referred to as “ALS”, and the party who is receiving
the right to use the licensed property will be referred to as “AII”.

 

The parties agree  as follows:

 

GRANT OF LICENSE. ALS owns Registered Trademark
of Arrestage and cosmetic formulas (“ARRESTAGE MARK & FORMULAS”). In accordance with this Agreement, ALS
grants AII an exclusive license to sell the ARRESTAGE MARK & FORMULAS. ALS retains title and ownership of the ARRESTAGE
MARK & FORMULAS.

 

All rights other than those specifically granted herein
to Licensee are reserved to Licensor, including without limitation, Licensors right to continue to use the Licensed Property in
any form, manner, and medium.

 

PAYMENT OF ROYALTY. All
will pay to ALS a royalty which shall be calculated as follows: $50,000 00/100. The royalty shall be paid in three
installments on or before the 15th day of the for which the royalty is applicable.

 

QUALITY CONTROL AND APPROVAL. Licensee understands and
agrees that an essential condition of this Agreement is the protection of the high reputation enjoyed by Licensor in the
Licensed Property, and that,    in keeping with that condition, any and all use of the Licensed
Property in connection with the Limited Purpose, including, without limitation, on any Materials, shall be of high and
consistent quality and subject to the approval and continuing supervision and control of Licensor. Upon the request
of Licensor, Licensee shall submit to Licensor, on an annual basis during the Term, one (1) sample, photograph or copy of
each of its Materials, including on signs, sales materials, and advertising materials bearing the Licensed Property prior to
any use thereof by or on behalf of Licensee. Should Licensor fail to notify Licensee in writing of any quality control issues
relating to the distribution of such Materials within thirty (30) days after receipt of such sample or copies,
those Materials will be deemed approved by Licensor as of the end of such thirty (30) day period for the immediately
succeeding annual period of the Term. The parties shall negotiate in good faith to resolve any quality control issues of
which Licensor may notify Licensee.

 

MODIFICATIONS. Unless the prior written approval of ALS
is obtained, AII may not modify or change the ARRESTAGE MARK & FORMULAS in any manner.

 

     

     

    

 

DEFAULTS. If AII fails to abide by the obligations of this
Agreement, including the obligation to make a royal payment when due, ALS shall have the option to cancel this Agreement by providing
30 days days written notice to AII. AII shall have the option of preventing the termination of this Agreement by taking corrective
action that cures the default, if such corrective action is taken prior to the end of the time period stated in the previous sentence,
and if there are no other defaults during such time period.

 

OWNERSHIP OF LICENSED PROPERTY AND PROTECTION OF RIGHTS.
Licensee acknowledges and agrees that Licensor owns all rights, title, and interest in and to the Licensed Property, and Licensee
will not challenge in any court of law or in any other manner the validity of the Licensed Property of Licensed Property, alone
or as part of its own service marks, trademarks, or trade names, in the U.S. or with any other governmental entity anywhere in
the world. Except as expressly authorized by Licensor in writing, Licensee shall not use the Licensed Property or any similar
Licensed Property as, or as part of, a trademark, service mark, trade name, fictitious name, company or corporate name, or Internet
domain name anywhere in the world. In connection with its use of the Licensed Property, Licensee will not in any manner represent
that it has any ownership right in the Licensed Property, and Licensee acknowledges that all use of the Licensed Property by Licensee
shall inure to the benefit of Licensor.

 

ARBITRATION. All disputes under this Agreement that cannot
be resolved by the parties shall be submitted to arbitration under the rules and regulations of the American Arbitration Association.
Either party may invoke this paragraph after providing 30 days written notice to the other party. All costs of arbitration shall
be divided equally between the parties. Any award may be enforced by a court of law.

 

WARRANTIES. Neither party
makes any warranties with respect to the use, sale or other transfer of the ARRESTAGE MARK & FORMULAS by the other party or
by any third party, and All accepts the product “AS IS.” In no event will ALS be liable for direct, indirect, special,
incidental, or consequential damages, that are in any way related to the ARRESTAGE MARK & FORMULAS.

 

INDEMNIFICATION.
Licensee is solely responsible for, and will defend, indemnify and hold harmless Licensor, its affiliates, and their
respective shareholders, directors, officers, employees, agents and sponsors from any and all loss, costs, expenses including
reasonable attorney’s fees, claims demands, liabilities, settlements, causes of action or damages, arising out of the
marketing, sale or distribution of the Materials. The Licensor shall indemnify the Licensee from a claim by a third party that
an authorized use of the Licensed Property by Licensee in the U.S. infringes or otherwise violates any copyright, trademark or
other proprietary right of a third party.

 

NO JOIN VENTURE OR
ENDORSEMENT OF LICENSEE. The relationship between the parties hereto is solely that of licensee and licensor, and nothing
herein shall be deemed or construed to create any franchise, joint venture, partnership or any fiduciary relationship other
than that of licensee and licensor. Licensee shall have no power to obligate or bind Licensor in any manner whatsoever or to
make any contract, warranty, or representation on behalf of Licensor and shall not represent itself to the third parties as
having such power.

 

    	 	2	 

     

    

 

TRANSFER OF RIGHTS. This Agreement shall
be binding on any successors of the parties. Neither party shall have the right to assign its interests in this Agreement
to any other party, unless the prior written consent of the other party is obtained.

 

TERMINATION. This Agreement
shall terminate automatically on 2025.

 

Licensor may immediately terminate this Agreement, or the
license granted hereunder, without prejudice to any other rights it may have under the provisions of this Agreement, in law,
in equity or otherwise, upon written notice to Licensee at any time if: (i) Licensee shall be in breach of any material term
or obligation of this Agreement, and fail to cure such breach within thirty (30) days after receipt of written notice from
Licensor; (ii) any Materials actually used are of lower quality than the samples approved by Licensor; or (ii) Licensee shall
commit any act or shall fail to act in a way that Licensor reasonable believes is likely to harm or adversely affect, in a
material way, the goodwill, reputation or interests of Licensor in the Licensed Property.

 

EFFECT OF  TERMINATION AND SURVIVAL OF OBLIGATIONS.
Following expiration or termination of this Agreement, all rights granted to Licensee hereunder shall revert to Licensor, and
Licensee will cease from any and all further use of the Licensed Property, except that Licensee may continue to distribute only
those approved Materials in inventory at the time of expiration or termination.

 

ENTIRE
AGREEMENT. This Agreement contains the entire agreement of the parties and there are no other promises or conditions
in any other agreement whether oral or written. This Agreement supersedes any prior written or oral agreements between the
parties.

  

CONFIDENTIALITY. Each party shall keep
the specific terms of this Agreement confidential, including the financial  terms.

 

AMENDMENT. This Agreement may be modified
or amended, if the amendment is made in writing and is signed by both parties.

 

SEVERABILITY. If any provision of this
Agreement shall be held to be invalid or unenforceable for any reason, the remaining provisions shall continue to be valid and
enforceable. If a court finds that any prove ion of this Agreement is invalid or unenforceable, but that by limiting such provision
it would become valid or enforceable, then such provision shall be deemed to be written, construed, and enforced as so limited.

 
 WAIVER
OF CONTRACTUAL RIGHT. The failure of either party to enforce any provision of this Agreement shall not be construed as a
waiver or limitation of that party’s right to subsequently enforce and compel strict compliance with every provision of this
Agreement.

 

APPLICABLE LAW. This Agreement shall
be governed by the laws of the State of Nevada.

 

    	 	3	 

     

    

 

SIGNATURES. This Agreement shall be
signed on behalf of ALS by Kimberly Shapiro, and on behalf of AII by Ann Lili Shapiro.

 

Licensor:

Ann Shapiro

 

	By:	/s/ Kimberly Shapiro	 
	 	Kimberly Shapiro	 

 

Licensee:

Arrestage International Inc.

 

	By:	/s/ Ann Lili Shapiro	 
	 	Ann Lili Shapiro	 

 

 

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]